- Report
- May 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- May 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- May 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- April 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- September 2026
- 142 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 245 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 140 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 212 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 381 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 214 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 375 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 303 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 486 Pages
Global
From €5318EUR$5,850USD£4,572GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more